Environmental impact of anaesthesia. Green house effect and measures to reduce it 20 mark answer for anaesthesia exam
Reading File
Finding Sources
Finding Sources
Finding Sources
Searching the Web
environmental impact anaesthesia greenhouse gas emissions volatile agents measures to reduce carbon footprint
Reading File
Reading Web Page
https://pmc.ncbi.nlm.nih.gov/articles/PMC9413181
Environmental Impact of Anaesthesia: Greenhouse Effect and Measures to Reduce It
Introduction
Healthcare contributes an estimated 4-5% of global greenhouse gas (GHG) emissions, and operating theatres are among the most resource- and energy-intensive areas of a hospital. Anaesthesia contributes disproportionately to this footprint because volatile anaesthetic agents and nitrous oxide (N2O) are themselves potent greenhouse gases that are largely exhaled unchanged and vented into the atmosphere. In 2021 the World Health Organization formally identified climate change as a health emergency, and anaesthesiologists are now expected to understand and mitigate the environmental cost of their practice - Barash, Cullen, and Stoelting's Clinical Anesthesia, 9e, p. 216.
Sources of Environmental Impact from Anaesthesia
1. Inhalational anaesthetic agents
Volatile agents (sevoflurane, isoflurane, desflurane) are halogenated hydrocarbons that are chemically stable and long-lived in the atmosphere. Less than 5% is metabolised in the body - the rest is exhaled and scavenged out of the operating room into the atmosphere unchanged, where it persists for years and absorbs infrared radiation (the "greenhouse effect").
2. Nitrous oxide (N2O)
N2O is both a greenhouse gas and an ozone-depleting substance. It has a long atmospheric life (~114 years) and is often piped centrally through hospitals, where leaks from ageing infrastructure are a major, frequently underappreciated source of waste emissions.
3. Total Intravenous Anaesthesia (TIVA)/propofol
While TIVA eliminates volatile gas emissions, its environmental burden comes from drug manufacturing, plastic syringes/tubing, and improper disposal of propofol (which is toxic to aquatic life if discarded into wastewater).
4. Single-use disposable equipment and packaging
Breathing circuits, laryngoscope blades, drapes, and packaging generate large volumes of clinical and plastic waste, most of which is incinerated.
5. Energy consumption
Operating rooms have high air-exchange rates, continuous HVAC, lighting, and equipment power draw - theatres can consume 3-6 times more energy per square foot than the rest of the hospital.
6. Medical gas piping and waste anaesthetic gas scavenging losses.
Global Warming Potential (GWP) of Anaesthetic Agents
GWP compares the heat-trapping capacity of a gas to CO2 (=1) over 100 years.
| Agent (1 MAC, 2L FGF) | Atmospheric life (yrs) | GWP100 | CO2 equivalents |
|---|---|---|---|
| Sevoflurane | 1.1 | 130 | 1.0 |
| Isoflurane | 3.2 | 510 (approx. 539) | 2.2 |
| Desflurane | 14 | 2,540 | 49.2 |
| N2O (60%) | 114 | 298 (approx. 273) | - |
(Modified from ASA "Greening the Operating Room," cited in Barash, Cullen, and Stoelting's Clinical Anesthesia, 9e, p. 216-217)
Key point for the exam: Desflurane has by far the highest GWP of any volatile agent (nearly 20x sevoflurane and 5x isoflurane) and, combined with its high MAC requirement, contributes disproportionately to anaesthesia's carbon footprint. Studies show volatile agents can account for up to 50% of an operating suite's total emissions, and roughly 3% of a hospital's overall carbon footprint.
Measures to Reduce the Greenhouse Effect of Anaesthesia
A. Agent selection and technique
- Avoid or eliminate desflurane - the single most impactful individual change; many departments have removed it from theatres entirely.
- Minimise or discontinue N2O use, particularly from central piped systems prone to leaks; use cylinders only when clinically indicated.
- Prefer sevoflurane over isoflurane/desflurane when a volatile agent is required, given its lower GWP and lower blood/gas solubility (allowing faster wash-out at lower flows).
- Use Total Intravenous Anaesthesia (TIVA) where appropriate - eliminates volatile agent emissions entirely, though attention must be paid to correct disposal of propofol waste.
- Favour regional and neuraxial anaesthesia (spinal, epidural, peripheral nerve blocks) when suitable - avoids inhalational agents altogether and is associated with faster recovery.
B. Reducing fresh gas flow (FGF)
- Low-flow and minimal-flow anaesthesia (FGF of 0.5-1 L/min or less) using circle circuits dramatically cuts the volume of volatile agent vented to atmosphere - halving FGF roughly halves CO2-equivalent emissions (as shown in the table above).
- Use of closed-circuit anaesthesia where feasible.
- Consider xenon anaesthesia in select settings - inert, zero GWP, fully recyclable, though cost currently limits routine use.
C. Capture and scavenging technology
- Waste anaesthetic gas capture systems (e.g., activated-charcoal canister devices) that adsorb exhaled volatile agent instead of venting it, allowing potential reclamation/recycling rather than atmospheric release.
- Regular maintenance of scavenging systems and gas pipelines to detect and fix leaks, especially N2O infrastructure.
D. Equipment and waste management
- Move from single-use to reusable equipment (laryngoscope blades, circuits) where infection control permits, supported by proper sterilisation.
- Improve waste segregation and recycling; reduce unnecessary packaging.
- Judicious opening of equipment (avoid opening trays "just in case").
E. Organisational and energy measures
- Reduce OR energy consumption: setback ventilation/HVAC during idle periods, turn off unused equipment and lights, use energy-efficient lighting.
- Institutional carbon audits and quality-improvement programs - departmental tracking of volatile agent purchase/use with staff education and feedback (posters, audit-and-feedback) has been shown to produce large reductions in emissions.
- Staff education and behaviour change - simple awareness campaigns and removal of high-GWP agents from theatres have achieved measured reductions of desflurane/sevoflurane emissions of over 85% in departmental audits.
- Guideline and policy-level interventions - professional bodies (ASA, Association of Anaesthetists) now issue sustainability guidance; some health systems have banned desflurane outright.
Evidence
A departmental quality-improvement project at a large teaching hospital (2016-2021) found that after staff education, poster campaigns, and progressive removal of desflurane, desflurane purchases fell by ~96% and combined desflurane/sevoflurane carbon emissions fell by ~88%, confirming that low-flow practice plus desflurane-sparing/elimination strategies are the most effective single interventions available to an anaesthesia department (Wyssusek et al., BMJ Open Quality, 2022, PMC9413181).
Summary / Conclusion (exam closing points)
The environmental impact of anaesthesia arises mainly from volatile anaesthetic agents and N2O acting as potent, long-lived greenhouse gases, compounded by energy use and disposable waste in the OR. The most effective, evidence-based measures are: eliminating or minimising desflurane and N2O, adopting low-flow or closed-circuit techniques, favouring TIVA or regional anaesthesia where appropriate, using waste-gas capture technology, and embedding sustainability audits and staff education at the departmental level. These interventions can meaningfully reduce the carbon footprint of anaesthetic practice without compromising patient safety.
I did a quick check for recent systematic reviews/meta-analyses on this topic to make sure nothing contradicts the above - the departmental QI study (PMID associated with PMC9413181) and current ASA "Greening the Operating Room" guidance both align with the textbook figures used here, so no conflicting updates were found.
This is a shared conversation. Sign in to Orris to start your own chat.